^a Tested in dextrose 5%.

^b Tested in sodium chloride 0.9%.

^c Tested in both dextrose 5% and sodium chloride 0.9%.

^d Tested in sterile water for injection.

^e Lyophilized formulation tested.

^f Tested in sodium chloride 0.45%.

^g Injected via Y-site into an administration set running azithromycin.

^h Final concentration after mixing.

ⁱ Test performed using the formulation WITHOUT edetate disodium.

^j Test performed using the Cubicin formulation.

^k Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.

^l Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.

^m Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.

ⁿ Test performed using the formulation WITH edetate disodium.

^o Tested as the premixed infusion solution.

^p Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.

^q Subvisible particulate test methods include light obscuration, flow imaging microscopy, and backgrounded membrane imaging.